Canadian paediatricians' opinions on rotavirus vaccination

E Dubé1, V Gilca, C Sauvageau

  • 1Institut national de santé publique du Québec, 2400 d'Estimauville, Québec, Québec, Canada. eve.dube@ssss.gouv.qc.ca

Vaccine
|March 8, 2011
PubMed

Insights

Pediatricians in Canada view rotavirus disease as a significant health and economic burden, yet their intention to recommend rotavirus vaccines remains low, impacting vaccine uptake.

Area of Science:

  • Pediatric Infectious Diseases
  • Vaccinology
  • Public Health Policy

Background:

  • Rotavirus is a primary cause of severe gastroenteritis and hospitalization in young children globally.
  • Two safe and effective rotavirus vaccines are available but not publicly funded in Canada.
  • Understanding healthcare provider perspectives is crucial for vaccine implementation.

Purpose of the Study:

  • To assess Canadian pediatricians' knowledge, attitudes, and beliefs (KAB) regarding rotavirus disease and vaccination.
  • To identify factors influencing pediatricians' intention to recommend rotavirus vaccines.
  • To evaluate the potential impact of public funding on vaccine uptake.

Main Methods:

  • Anonymous, self-administered questionnaire based on the Health Belief Model and immunization program frameworks.
  • Mailed survey to 1852 Canadian pediatricians, achieving a 50% response rate.
  • Multivariate analysis to determine key predictors of recommendation intention.

Main Results:

  • Most pediatricians perceived rotavirus disease as moderately consequential and a significant economic burden.
  • 69% considered rotavirus vaccines safe; 61% considered them effective.
  • Perceived disease burden strongly predicted intention to recommend (R²=0.49, p<0.0001), while adverse event risk was a key barrier.

Conclusions:

  • While over half of pediatricians are willing to recommend rotavirus vaccines, strong intention is low compared to other vaccines.
  • Low uptake is anticipated without public funding, mirroring challenges with other new vaccines.
  • Addressing perceived barriers and highlighting disease burden are key for improving rotavirus vaccine recommendation rates.

Related Concept Videos

Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Vaccinations01:51

Vaccinations

Overview
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...